Simplify Logo
Achira

Achira

Atomistic drug-discovery simulation platform

Machine Learning Research Engineer - Research

Full-Time
$164.6k - $259k/yr
Mid
San Francisco, CA, USA+1 more

More locations: New York, NY, USA

Hybrid

Hybrid work is available in San Francisco or New York City, with travel to San Francisco as needed.

About the job

Requirements
  • Strong software engineering fundamentals, including experience building reproducible research pipelines, writing documentation, and following coding best practices.
  • A track record of observable artifacts, such as GitHub repositories or papers, demonstrating work in machine learning or scientific computing libraries.
  • Working knowledge of PyTorch, JAX, and the modern machine learning research stack.
  • Comfort working with high-performance computing or large-scale compute environments and running hundreds or thousands of simultaneous model fits.
  • Sufficient scientific depth to engage with the research questions, developed through prior industry experience or a PhD.
Responsibilities
  • Design and run experiments to test hypotheses supporting foundation model development.
  • Engineer meaningful evaluations and metrics that enable rapid model iteration.
  • Design, build, and maintain scalable, reproducible libraries for training, experimentation, evaluation, and simulation in support of large-scale research initiatives.
  • Implement model architectures from the literature and architectures developed with in-house researchers for molecular simulation.
  • Enable agent-driven research and workflows and maintain guardrails on agentic tooling.
  • Help prepare manuscripts, software artifacts, and datasets for public release.
Desired Qualifications
  • Experience with equivariant architectures, geometric deep learning, or graph neural networks, including NequIP, MACE, SchNet, PaiNN, or similar.
  • Familiarity with generative modeling, including diffusion models, flow matching, or score-based methods.
  • Regular involvement in open-source machine learning or scientific computing libraries.
  • Experience building agent-driven research, active learning, and data curation pipelines.

About the company

Achira develops atomistic foundation simulation models for drug discovery, combining geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced potentials and generative models. These models produce large synthetic datasets free from experimental artifacts, enabling true inverse design where researchers optimize compounds from desired properties. Achira serves pharmaceutical and biotech clients through partnerships, licensing, and collaborations, differentiating itself by integrating physics-based simulations with data-driven learning to mitigate data scarcity and high costs. The company's goal is to accelerate and make drug discovery more reliable by enabling inverse design that reduces time and expenses in identifying promising compounds.

Company Size

11-50

Company Stage

Seed

Total Funding

$33M

Headquarters

New York City, New York

Founded

2024

Get referred to Achira

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Achira raised $33 million from Dimension, NVIDIA, Amplify, and Compound in 2025.
  • June 2026 NVIDIA collaboration signals active distribution leverage and technical validation.
  • Hiring for ML researchers and software engineers shows continued expansion across core product functions.

What critics are saying

  • Achira has no disclosed commercial customers, leaving revenue unproven beyond partnerships.
  • Drug-discovery validation cycles take years; first models were only expected during 2025.
  • If physics-grounded models underperform experiments, Achira becomes an expensive research lab, not a business.

What makes Achira unique

  • Achira blends atomistic simulation, quantum chemistry, and geometric deep learning for molecular world models.
  • Founders John Chodera and Theofanis Karaletsos bring elite drug discovery and ML credentials.
  • NVIDIA-backed BioNeMo collaboration positions Achira inside life-sciences infrastructure, not a standalone model vendor.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO/vacation

Paid Vacation

Paid Holidays

Unlimited Paid Time Off

401(k) Retirement Plan

Stock Options

Company Equity

Wellness Program

Mental Health Support

Gym Membership

Conference Attendance Budget

Professional Development Budget

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Confluence

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

12%
The National Herald
Apr 10th, 2025
Achira AI Secures $33M in Funding

Greek startup Achira AI has secured $33 million in funding from top investors, including Dimension, Nvidia, Amplify, and Compound. Achira aims to revolutionize AI-enabled drug development by integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced simulation models. This approach seeks to overcome limitations in current biomolecular simulations and machine learning models, accelerating the discovery of new molecules and treatments.

Endpoints News
Feb 21st, 2025
Nvidia-backed Achira debuts, blending AI and physics to model molecules

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ultimately helped lead to his new job. The computational ...